期刊文献+

中耳胆脂瘤发病机制及分子生物学基础 被引量:2

暂未订购
导出
摘要 自从德国生理学家JohannesMfieller于1838年首次提出“胆脂瘤”概念以来.各家学者对其发病机制的研究作了大量的工作,但其局部的膨胀压迫性生长和骨破坏性作用机制仍不明了。后天性胆脂瘤的临床特征是以复层鳞状上皮向中耳腔内生长,形成囊袋,角化上皮组织不断堆积,逐渐扩展累及邻近结构导致听力损失、前庭功能障碍、面神经麻痹和颅内外一系列并发症。本文复习既往的文献对中耳胆脂瘤的发病机制及分子生物学基础的论述。
出处 《中华耳科学杂志》 CSCD 2007年第2期168-170,共3页 Chinese Journal of Otology
  • 相关文献

参考文献13

  • 1[1]Tos M.Manual of middle ear surgery.Stuttgart,New York:Thieme,1995.
  • 2[2]Tos M,Lau T.Recurrence and the condition of the cavity after surgery for cholesteatoma using various techniques.Amsterdam:Kugler and Ghedini,1989.
  • 3[3]Saleh HA,Mills RP Classification and staging of eholesteatoma.Clin Otolaryngol Allied Sci,1999,24(4):355-359.
  • 4[4]Naim R,Linthicum F Jr,Shen T,et al.Classification of the external auditory canal cholesteatoma.Laryngoscope,2005,115(3):455-460.
  • 5[5]Northrop C,Piza J,Eavey RD.Histological observations of anmiotic fluid cellular content in the ear of neonates and infants.Int J Pediatr Otorhinolaryngol,1986,11(2):113-127.
  • 6[6]Kojima H,Miyazaki H,Shiwa M,et al.Molecular biological diagnosis of congenital and aquired cholesteatoma on the basis of differences in telomere length.Laryngoscope,2001,111(5):867-873.
  • 7[7]Sohn SJ.Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors.Acta Otolaryngol,2005,125(2):130-133.
  • 8[8]Jung JY,Pashia ME,Nishimoto SY,et al.A possible role for nitric oxide in Osteoclastogenesis associated with cholesteatoma.Otol Neurotol,2004,25(5):661-668.
  • 9[9]Yetiser S,Satar B,Aydin N.Expression of epidermal growth factor,tumor necrosis factor-alpha,and interleukin-1 alpha in chronic otitis media with or without eholesteatoma.Otol Neurotol,2002,23(5):647-652.
  • 10[10]Schonermark M,Mester B,Kempf HG,et al.Expression of matrixmetalloproteinases and their inhibitors in human cholesteatomas.Acta Otolaryngol,1996,116(3):451-456.

同被引文献36

  • 1Louw L.Acquired cholesteatoma pathogenesis:stepwise explana tions.J Laryngol Otol.2010,124(6):587-593.
  • 2Kuo CL.Etiopathogenesis of acquired cholesteatoma:prominent the ories and recent advances in biomolecular research.Laryngo scope.2015,125(1):234-240.
  • 3Park MK,Lee BD.Development of animal models of otitis media Korean J Audiol.2013,17(1):9-12.
  • 4Yamamoto-Fukuda T,Takahashi H,Koji T.Animal models of mid dle ear cholesteatoma.J Biomed Biotechnol.2011,2011:394241.
  • 5Chole RA,Henry KR,Mc Ginn MD.Cholesteatoma:spontaneous oc currence in the Mongolian gerbil Meriones unguiculatis.Am Otol.1981,2(3):204-210.
  • 6Mc Ginn MD,Chole RA,Henry KR.Cholesteatoma.Experimental in duction in the Mongolian Gerbil,Meriones Unguiculaus.Acta Otolar yngol.1982,93(1-2):61-67.
  • 7Jung JY,Lee DH,Wang EW,et al.P.aeruginosa infection increas es morbidity in experimental cholesteatomas.Laryngoscope.2011121(11):2449-2454.
  • 8Chole RA,Gagnon PM,Vogel JP.Inactivation of specific Pseudomo nas aeruginosa biofilm factors does not alter virulence in infecte cholesteatomas.Otol Neurotol.2014;35(9):1585-1591.
  • 9Yamamoto-Fukuda T,Hishikawa Y,Shibata Y,et al.Pathogenesi of middle ear cholesteatoma:a new model of experimentally induce cholesteatoma in Mongolian gerbils.Am J Pathol.2010,176(6)2602-2606.
  • 10Park K,Park HJ,Chun YM.Immunohistochemical study on prolifer ative activity of experimental cholesteatoma.Eur Arch Otorhinolar yngol.2001,258(3):101-105.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部